Cybersecurity is a concern for two-thirds of pharmaceutical C-suites (66%), according to a recent survey from Rackspace and Microsoft. The priority came ahead of supply chain/logistics management (55%) and sustainability (53%). See full data below: Data breaches in the pharma sector are costly, with the average cost of remediation topping $10 million in 2022, according…

With the pandemic continuing to disrupt the pharmaceutical industry, drug makers find themselves torn between the traditional domain of drug making and an emerging domain of new platforms and focuses. This disparity was reflected in the most popular pieces of content from Pharmaceutical Processing World in 2021. 1. GSK, Pfizer and J&J among the most-fined drug…